Table 2.
Descriptive statistics of user characteristics (N=9051).
| Characteristics | Participants | Minimum value of user characteristics | Maximum value of user characteristics | Total unknowna | ||
| Sociodemographics |
|
|||||
|
|
Gender, n (%) |
|
|
|
5402 | |
|
|
|
Female | 2075 (56.86) | 0 | 1 |
|
|
|
|
Male | 1574 (43.14) | 0 | 1 |
|
|
|
Ageb (n=8880), mean (SD) | 50.39 (13.48) | 16 | 94 | 171 | |
|
|
|
<30 years, n (%) | 719 (8.10) | 0 | 1 |
|
|
|
|
30-40 years, n (%) | 1184 (13.33) | 0 | 1 |
|
|
|
|
40-50 years, n (%) | 2103 (23.68) | 0 | 1 |
|
|
|
|
50-60 years, n (%) | 2541 (28.61) | 0 | 1 |
|
|
|
|
60-70 years, n (%) | 1737 (19.56) | 0 | 1 |
|
|
|
|
>70 years, n (%) | 596 (6.71) | 0 | 1 |
|
| Body measures |
|
|||||
|
|
Heightc (n=3646), mean (SD) | 169.70 (10.57) | 142.20 | 205.70 | 5405 | |
|
|
Weightd (n=3507), mean (SD) | 100.38 (29.24) | 45.36 | 300.00 | 5544 | |
|
|
BMIe (n=3321), mean (SD) | 34.83 (9.79) | 15.82 | 106.83 | 5730 | |
|
|
|
Underweight, n (%) | 21 (0.63) | 0 | 1 |
|
|
|
|
Normal weight, n (%) | 354 (10.66) | 0 | 1 |
|
|
|
|
Overweight, n (%) | 716 (21.56) | 0 | 1 |
|
|
|
|
Obese I, n (%) | 851 (25.62) | 0 | 1 |
|
|
|
|
Obese II, n (%) | 612 (18.43) | 0 | 1 |
|
|
|
|
Obese III, n (%) | 767 (23.10) | 0 | 1 |
|
| Diagnosis |
|
|||||
|
|
Type, n (%) |
|
|
|
894 | |
|
|
|
Type 1 diabetes | 1220 (14.96) | 0 | 1 |
|
|
|
|
Type 2 diabetes | 5747 (70.45) | 0 | 1 |
|
|
|
|
Prediabetes | 715 (8.77) | 0 | 1 |
|
|
|
|
Other | 475 (5.82) | 0 | 1 |
|
|
|
Duration, n (%) |
|
|
|
2562 | |
|
|
|
Newly diagnosed | 1780 (27.43) | 0 | 1 |
|
| Treatment regimen | 2147 | |||||
|
|
Number of registered medications (≥1) (n=6904), mean (SD) | 1.86 (0.97) | 1 | 11 |
|
|
|
|
Registered insulin, n (%) | 3890 (56.34) | 0 | 1 |
|
|
|
|
Registered bolus insulin, n (%) | 2334 (33.81) | 0 | 1 |
|
|
|
|
Registered other injectables, n (%) | 1160 (16.80) | 0 | 1 |
|
|
|
|
Registered orals, n (%) | 4372 (63.33) | 0 | 1 |
|
|
|
|
Number of oral substances (≥1) (n=4372), mean (SD) | 1.38 (0.64) | 1 | 6 |
|
|
| Control of disease, n (%) of well-controlled users |
|
|||||
|
|
On the basis of baseline BGf | 1569 (34.48) | 0 | 1 | 4501 | |
|
|
On the basis of baseline CGMg | 185 (38.14) | 0 | 1 | 8566 | |
| Demanded app modules, n (%) | 0 | |||||
|
|
Ever used medication tracker | 3933 (43.45) | 0 | 1 |
|
|
|
|
Ever used exercise | 1579 (17.45) | 0 | 1 |
|
|
|
|
Ever used food | 3821 (42.22) | 0 | 1 |
|
|
|
|
Ever used BG | 5015 (55.41) | 0 | 1 |
|
|
|
|
Ever used CGM | 559 (6.18) | 0 | 1 |
|
|
| User scope | 0 | |||||
|
|
Number of modules used (>0) (n=9051) mean (SD) | 1.65 (0.83) | 0 | 5 |
|
|
|
|
Used 1 module, n (%) | 5013 (55.39) | 0 | 1 |
|
|
|
|
Used 2 modules, n (%) | 2465 (27.23) | 0 | 1 |
|
|
|
|
Used 3 modules, n (%) | 1349 (14.90) | 0 | 1 |
|
|
|
|
Used 4 modules, n (%) | 203 (2.24) | 0 | 1 |
|
|
|
|
Used 5 modules, n (%) | 21 (0.23) | 0 | 1 |
|
|
aTotal unknown reflects the number of users who did not share their information for each user characteristic.
bAge in years (between 16 and 100 years).
cHeight in cm (between 140 and 220 cm).
dWeight in kg (between 45 and 300 kg).
eBMI groups according to the definition of the World Health Organization: underweight=BMI<18.5, normal weight=25>BMI≥18.5, overweight=30>BMI≥25, obese I=35>BMI≥30, obese II=40>BMI≥35, obese III=BMI≥40.
fBG: blood glucose.
gCGM: continuous glucose monitoring.